WCN26-2847 Bone disorders under aldosterone-salt hypertension uncovered by transcriptome-wide profiling

Read full text Summarise with VIRAT
Authors: MIKA KAWAGOE, Daigoro Hirohama, Masaki Ueno, Yoshifuru Tamura, Shigeru Shibata
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Mineralocorticoid receptor (MR) activation exerts broad pathological effects, and large outcome trials have established the cardiorenal-protective benefits of MR antagonists. Although clinical observations in primary aldosteronism suggest an increased risk of fractures and enhanced urinary calcium excretion, indicating a potential involvement of MR in the bone–kidney axis, its causal role and underlying mechanisms remain to be clarified. We aimed to define molecular and structural skeletal consequences of aldosterone–salt loading and evaluate the protective effects of esaxerenone, a selective non-steroidal MR antagonist.

Fields of Study & Subjects

Hormonal Regulation and Hypertension Bone health and osteoporosis research Parathyroid Disorders and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104430–104430
Publication date
25 March 2026
Language
EN